Building Innovation Subsidiaries in Emerging Markets: The Experience of Novo Nordisk

Nicolai Pogrebnyakov, Jonas D. Kristensen

    Research output: Contribution to journalJournal articleResearchpeer-review


    Innovation subsidiaries increasingly follow manufacturing subsidiaries into emerging markets. Compared to well-established Western economies, emerging markets present unique challenges for the development of innovation management capabilities at subsidiaries. This paper distinguishes between implementer and innovator subsidiaries and provides suggestions on how to transform an implementer subsidiary to an innovator. This transformation may start as a strategic priority within the company and then be translated into specific actions. Suggestions for actions are based on the experience of a large multinational pharmaceutical company, Novo Nordisk. Lessons learned include assigning the subsidiary responsibility for a self-contained piece of work while maintaining a central R&D function, balancing local and in-company management, using local innovation talent, and educating new hires into the company culture.
    Original languageEnglish
    JournalResearch Technology Management
    Issue number4
    Pages (from-to)30-37
    Publication statusPublished - 2011


    • Dynamic capabilities
    • Emerging markets
    • Subsidiaries

    Cite this